14/01/2010
ReGen Therapeutics Plc (“ReGen” or the “Company”), (AIM:RGT) is pleased to announce that it has conditionally placed 8,333,333 new ordinary shares at 1.5p per ordinary share to raise £125,000 before expenses for general working capital purposes.
The 8,333,333 new ordinary shares, which will represent 18.5 per cent of the enlarged issued share capital of the Company (in aggregate amounting to 45,063,215 ordinary shares on completion of the placing), will rankpari passu in all respects with the existing ordinary shares in the Company.
The Board sees this placing by our Broker as further evidence of the growing confidence in the investment community for ReGen’s future.
Application has been made to the London Stock Exchange for the new ordinary shares to be admitted to trading on AIM and admission is expected to commence on or around Tuesday, 19 January 2010.
For further information, please contact:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396
David Scott/Nick Bealer
Alexander David Securities Limited
Tel: 020 7448 9820